José Mejía Oneto, Shasqi CEO
A better way to control where drugs go? Investors bet on small biotech's mission to 'click' together cancer meds
While José Mejía Oneto was an orthopedic surgery resident at UC Davis, he learned an intriguing yet frustrating fact: Only small amounts of a drug …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
